Two wide-ranging cannabis bills cleared a key legislative hurdle today in Massachusetts, with the Joint Committee on Cannabis Policy voting to report both measures favorably and referring them to the Senate Committee on Ways and Means for further consideration.
The first proposal, Senate Bill 99, would make sweeping changes to how the state’s regulated marijuana market operates, with a focus on market structure, licensing limits, enforcement, and the fast-growing intoxicating hemp sector. The bill would cap how many licenses a single person or entity with direct or indirect control may hold statewide, limiting control to no more than nine marijuana retailer licenses, three medical marijuana treatment center licenses, three product manufacturer licenses, and three cultivator licenses. The bill would also prohibit the Cannabis Control Commission from granting a new retail license if it would result in a person or entity controlling four or more retailers, allowing expansion beyond that threshold only through a change of ownership or control of an existing license.
The measure also establishes a detailed statutory framework for regulating intoxicating hemp-derived cannabinoid products and THCA. It defines a wide range of chemical terms and compounds, including delta-8 THC, delta-9 THC, isomers and isomerization, decarboxylation, cannabimimetic compounds, and “intoxicating tetrahydrocannabinols.” Under the bill, any business selling hemp-derived cannabinoid products or THCA above specified THC thresholds would be required to obtain an “intoxicating hemp endorsement” from the Cannabis Control Commission. The bill also sets penalties for violations, while preserving the ability to cultivate and transport federally compliant hemp.
Senate Bill 99 further proposes several operational and compliance changes for licensed marijuana businesses. It would establish a single agent registration card usable across multiple marijuana establishments and laboratories, valid for seven years, and prohibit registration fees for verified employees of social equity businesses. The bill conditions license renewal on the submission of a certificate of good standing and tax compliance, bars the commission from requiring sampling of any marijuana batch under 40 pounds, and limits the commission’s ability to prohibit advertising of sales, discounts, and customer loyalty programs within licensed establishments, delivery services, establishment websites, and opt-in email campaigns. It also updates rules governing credit between licensees by establishing a 60-day payment framework and a formal delinquency process overseen by the commission.
The bill also includes a temporary pause on issuing new marijuana retailer, cultivator, and product manufacturer licenses, with exceptions for pending applications deemed complete before the effective date, change-of-ownership requests, and social equity program participants. During that pause, the Joint Committee on Cannabis Policy would be required to conduct and publish a study examining market profitability, license density, cannabis supply levels, and enforcement practices, including whether oversupply is harming licensees and whether existing cultivation tiers remain appropriate.
The second bill, Senate Bill 75, takes a more targeted approach to updating Massachusetts marijuana laws, focusing on regulatory efficiency, transparency, and testing standards. The proposal would revise statutory definitions related to ownership and control and increase the adult possession limit from one ounce to up to three ounces of marijuana, while raising the concentrate limit from 5 grams to 15 grams and replacing the current per-product edible limits with a 1.5-gram total THC possession cap for edible, beverage, or other ingestible products.
Senate Bill 75 would also streamline employee and agent registration by creating a single agent registration card usable across multiple licensed marijuana businesses and independent testing laboratories. The card would be valid for six years, with a self-attestation required every two years, and fees would be waived for social equity participants and verified employees of social equity businesses. The bill further limits testing requirements by barring the Cannabis Control Commission from requiring testing of environmental media such as soil, water, or growing media, instead focusing mandatory testing on finished marijuana and marijuana products.
Another major component of Senate Bill 75 centers on laboratory oversight and transparency. The bill would require the commission to collect and publish quarterly testing data from independent laboratories, including failure rates for pesticides, heavy metals, microbiological contaminants, residual solvents, and mycotoxins, along with average THC levels across major product categories. The commission would also be required to investigate and publicly report on statistically significant testing outliers.
Both bills now move to the Senate Committee on Ways and Means, which will decide whether to advance them to the full Senate.
Sponsored
